Author

Amrita Nallathambi

MRC Laboratory of Molecular BiologyPrimary ORCID profile (0000-0001-5066-9528 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Amrita NallathambiiD1 paper · University of North Carolina at Chapel Hill

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:protein structure· 1 Approach:statistical model· 1

Frequent Co-Authors

Amir MotmaeniD· 1 shared Ana-Maria BratovianuiD· 1 shared André LieberiD· 1 shared Anja Bennett· 1 shared Annu Dalal· 1 shared Arun K. ShuklaiD· 1 shared Arvind S. PillaiiD· 1 shared Ayodeji A. Asuni· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Amir MotmaenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

De novo design of miniprotein agonists and antagonists targeting G protein-coupled receptors

Edin Muratspahić, David Feldman, David E. Kim, Xiangli Qu, Ana-Maria Bratovianu, Paula Rivera-Sánchez, Jan Hendrik Voss, Emil Peter Thrane Hertz, Mads Jeppesen, Federica Dimitri, Kensuke Sakamoto, Amrita Nallathambi, Pia Peceli, Jianjun Cao, Brian P. Cary, , David A. Baker

This paper presents computational methods for designing GPCR-binding miniproteins and validates them through high-throughput screening, producing agonists and antagonists for multiple GPCRs.

bioRxiv · Mar 23, 2025 · PreprintBioengineering